Moderna's Flu Vaccine Success Boosts COVID-19 Combo Shot Prospects
TL;DR Summary
Moderna's experimental mRNA flu vaccine showed stronger immune responses than existing vaccines in a late-stage trial, paving the way for approval and the development of a combined COVID and flu vaccine, with plans to resubmit applications later this year amid regulatory discussions.
Reading Insights
Total Reads
0
Unique Readers
2
Time Saved
3 min
vs 3 min read
Condensed
93%
597 → 42 words
Want the full story? Read the original article
Read on CNBC